Company profile
TScan Therapeutics, Inc. insider acquisitions
Company CIK 0001783328 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 22, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | Voting Common StockNon-derivative · Currency not specified | 2 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
5 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 1, 2026 | TScan Therapeutics, Inc.Voting Common Stock | MacBeath Gavin | Stock award |
| Oct 1, 2026 | TScan Therapeutics, Inc.Voting Common Stock | ZDRAVESKI ZORAN | Stock award |
| Dec 23, 2025 | TScan Therapeutics, Inc.Common Stock | Nichols Weston · Lynx1 Capital Management LP | Purchase |
| Dec 22, 2025 | TScan Therapeutics, Inc.Common Stock | Nichols Weston · Lynx1 Capital Management LP | Purchase |
| Dec 19, 2025 | TScan Therapeutics, Inc.Common stock, $0.0001 par value per share ("Common Stock") | Nichols Weston · Lynx1 Capital Management LP | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
TCRX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | MacBeath GavinChief Executive Officer · Director | Stock awardVoting Common StockNon-derivative security · Code A | 1,000,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | ZDRAVESKI ZORANSee Remarks | Stock awardVoting Common StockNon-derivative security · Code A | 300,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Nichols Weston10% owner Lynx1 Capital Management LP10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 6,232 | 0.8989 *Value: 5,601.9448Currency not specified | View ↗ |
| Trade: | Nichols Weston10% owner Lynx1 Capital Management LP10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 75,500 | 0.9Value: 67,950Currency not specified | View ↗ |
| Trade: | Nichols Weston10% owner Lynx1 Capital Management LP10% owner Joint filing · amounts unallocated | PurchaseCommon stock, $0.0001 par value per share ("Common Stock")Non-derivative security · Code P | 80,069 | 0.8989 *Value: 71,974.0241Currency not specified | View ↗ |
5 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →